Evidence map›Paper›PMID 37374915›Full record

ArticleMicroorganisms2023

Multi-Approach Characterization of Novel Pyrene-Degrading

Natalia Maria Silva, Camila Lopes Romagnoli, Caio Rafael do Nascimento Santiago, João Paulo Amorim de Lacerda, Sylvia Cardoso Leão, Luciano Antonio Digiampietri, Cristina Viana-Niero

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Description of new species ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Natalia Maria SilvaDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo 04023-901, Brazil.
Camila Lopes RomagnoliDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo 04023-901, Brazil.
Caio Rafael do Nascimento SantiagoSchool of Arts, Sciences and Humanities, University of São Paulo, São Paulo 03828-000, Brazil.
João Paulo Amorim de LacerdaLaboratory of Chemistry and Manufactured Products, Institute of Technological Research, São Paulo 05508-901, Brazil.ORCID 0000-0003-0577-5270
Sylvia Cardoso LeãoDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo 04023-901, Brazil.
Luciano Antonio DigiampietriSchool of Arts, Sciences and Humanities, University of São Paulo, São Paulo 03828-000, Brazil.
Cristina Viana-NieroDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo 04023-901, Brazil.ORCID 0000-0002-1068-7884
Universidade Federal de São Paulo · BRUniversidade de São Paulo · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001National Council for Scientific and Technological Development 406710/2018-0São Paulo Research Foundation 2019/14137-4
6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are chemical compounds that are widespread in the environment, arising from the incomplete combustion of organic material, as well as from human activities involving petrol exploitation, petrochemical industrial waste, gas stations, and environmental disasters. PAHs of high molecular weight, such as pyrene, have carcinogenic and mutagenic effects and are considered pollutants. The microbial degradation of PAHs occurs through the action of multiple dioxygenase genes (

Indexed as

gas chromatography/mass spectrometrygenomic analysispolycyclic aromatic hydrocarbon

Identifiers

PMID37374915
PMCPMC10301208
OpenAlexW4378576037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.